Semprex-D

Active Ingredient(s): Acrivastine + Pseudoephedrine
FDA Approved: * March 25, 1994
Pharm Company: * UCB INC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Semprex-D Overview

Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine (like its base molecule triprolidine) and works by blocking histamine H1 receptors. This non-sedating[verification needed] antihistamine is sold under the brand name Benadryl Allergy Relief in the United Kingdom by McNeil Laboratories. It should not be confused with Benadryl Once a Day which has cetirizine as the active ingredient and is...

Read more Semprex-D Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Acrivastine

Recent Semprex-D Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Acrivastine + Pseudoephedrine
  • Capsule: 8mg + 60mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Semprex-D: (1 result)

Sorted by National Drug Code
  • 53014-404 Semprex-d (Acrivastine 8 mg / Pseudoephedrine Hydrochloride 60 mg) Oral Capsule by Ucb, Inc.

Drugs with one or more similar ingredients: (327 results)

Related Semprex-D Topics:

semprex-D
decongestant...
medeva semprex-d
white and green capsule...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA